{
  "id": 16623653,
  "title": "Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support",
  "url": "https://urgent.news/2026/10/26/seek-labs-expands-oncology-research-for-sequence-ablation",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-26T15:56:20.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/seek-labs-expands-oncology-research-for-sequence-ablation-therapeutics-with-up-to-3-million-in-foundation-support"
  },
  "original_language": "en",
  "account": null,
  "summary": "Two2Ten Foundation supports the continued development of Seek Labs’ Sequence Ablation Therapeutics (SAT) platform into oncology, honoring the memory of Travis Snyder SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) — Seek Labs, a Salt Lake City Tech Bio company developing programmable CRISPR-based medicines, today announced an agreement with the Two2Ten Foundation providing up to […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}